The evidence for a change in antenatal HIV screening policy in Australia

Medical Journal of Australia

Volumn 185, Issue 4, 2006, Pages 217-220

  Giles, Michelle L ^a,c   Hellard, Margaret E ^b,c   Lewin, Sharon R ^a,c   Mijch, Anne M ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; DEVELOPED COUNTRY; EVIDENCE BASED MEDICINE; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH STATUS; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL SOCIETY; MEDICAL SPECIALIST; PREGNANCY; PRENATAL CARE; PRENATAL SCREENING; RISK FACTOR; RISK REDUCTION; VIRUS TRANSMISSION;

EID: 33748325812     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00535.x     Document Type: Article

References (33)

1. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Antenatal screening tests. College statement 2004. http://www.ranzcog.edu.au/publications/statements/C-obs3.pdf (accessed Apr 2006).
2. Australian National Council on AIDS and Related Diseases (ANCARD). HIV testing policy. Canberra: Commonwealth Department of Health and Aged Care, 1998.
3. Hunt JM, Lumley J. Are recommendations about routine antenatal care in Australia consistent and evidence-based? Med J Aust 2002; 176: 255-259.
4. Giles ML, Sasadeusz JJ, Garland SM, et al. An audit of obstetricians' management of women potentially infected with blood-borne viruses. Med J Aust 2004; 180: 328-332.
5. Giles ML, Garland SM, Grover SR, et al. Impact of an education campaign on the management of pregnant women with a blood-borne virus. Med J Aust 2006; 184: 389-392.
6. Wilson JMG, Jungner G. Principles and practice of screening for diseases. Public Health Paper Number 34. Geneva: World Health Organization, 1968.
7. AIDSinfo. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States, Jul 2006. http://AIDSinfo.nih.gov (accessed Apr 2006).
8. British HIV Association. Guidelines for the management of HIV infection in pregnant women and the prevention of mother to child transmission of HIV. Mar 2005. http://www.bhiva.org (accessed Jul 2006).
9. Lindegren ML, Byers RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999; 282: 531.
10. Lansky A, Jones JL, Frey RL, Lindegren ML. Trends in HIV testing among pregnant women: United States 1994-1999. Am J Public Health 2001; 91: 1291.
11. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2004. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 2004.
12. McLaws ML, Brown AR, Cunningham PH, et al. Prevalence of maternal HIV infection based on anonymous testing of neonates, Sydney 1989. Med J Aust 1990; 153: 383-386.
13. Law MG, Dore G, McDonald A, Kaldor J. The use of back projection to estimate HIV prevalence among pregnant women in Australia. Pediatr AIDS HIV Infect 1996; 7: 331-336.
14. Spencer JD, Tibbits D, Tippet C, et al. Review of antenatal testing policies and practice for HIV and hepatitis C infection. Aust N Z J Public Health 2003; 27: 614-619.
15. Chaisson R, Keruly J. Race, sex, drug use and progression of human immunodeficiency virus disease. N Engl J Med 1995; 333: 751-756.
16. Cozzi Lepri A, Pezzotti P. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex followed for up to nine years from seroconversion. (Italian seroconversion study.) BMJ 1994; 309: 1537-1542.
17. Suligoi B. The natural history of human immunodeficiency virus infection among women compared with men. Sex Transm Dis 1997; 24: 77-83.
18. Abrams EJ, Weedon J, Bertolli J, et al. Aging cohort of perinatally human immunodeficinecy virus-infected children in New York City. New York City Pediatric Surveillance of Disease Consortium. Pediatr Infect Dis J 2001; 20: 511-517.
19. Gibb DM, Duong T, Tookey PA, et al. Decline in mortality, AIDS and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ 2003; 327: 1019-1024.
20. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ 1990; 301: 1183-1188.
21. Strathdee SA, Craib KJ, Hogg RS, et al. Long-term non progression in HIV infection. Lancet 1995; 346: 1372.
22. Saada M, Le Chenadec J, Berrebi A, et al. Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SEROCO Study Groups. AIDS 2000; 14: 2355-2360.
23. Dax EM, Arnott A. Advances in laboratory testing for HIV. Pathology 2004; 36: 551-560.
24. Ioannidis JPA, Abrams EJ, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis 2001; 183: 539-545.
25. The Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 506-510.
26. Australasian Society for HIV Medicine. US Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents incorporating commentary to adapt the guidelines to the Australian setting. Sydney: ASHM, 2005. http://ashm.org.au/aust_guidelines (accessed Jul 2006).
27. Postma MJ, Beck EJ, Mandalia S, et al. Universal HIV screening of pregnant women in England: cost effectiveness analysis. BMJ 1999; 318: 1656-1660.
28. Immergluck LC, Cull WL, Schwartz A, Elstein AS. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago. Pediatrics 2000; 105: E54.
29. Postma MJ, Beck EJ, Hankins CA, et al. Cost effectiveness of expanded antenatal HIV testing in London. AIDS 2000; 14: 2383-2389.
30. Patrick DM, Money DM, Forbes J, et al. Routine prenatal screening for HIV in a low-prevalence setting. CMAJ 1998; 159: 942-947.
31. Bramley D, Graves N, Walker D. The cost effectiveness of universal antenatal screening for HIV in New Zealand. AIDS 2003; 17: 741-748.
32. Graves N, Walker DG, McDonald AM, et al. Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia. J Infect Dis 2004; 190: 166-174.
33. Duval M, Faye A, Rohrlich P, et al. Failure of pediatric AIDS prevention despite maternal HIV screening in Paris, France. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 100-101.